Pharmalucence, Inc. (www.pharmalucence.com) has selected Robert Bosch Packaging Technology, Inc. (www.bosch.com) to provide a state-of-the-art isolated pharmaceutical filling line for the new Pharmalucence production facility being constructed in Billerica, MA.
Pharmalucence initiated construction of its new facility in early 2011. This facility is believed to be the first contract manufacturing resource in New England utilizing aseptic barrier technology. Glenn Alto, Pharmalucence President and CEO stated, "Pharmalucence has purchased the most advanced aseptic manufacturing technology available to support its expansion into the business of pharmaceutical contract manufacturing. Our investment in Bosch technologies will help us achieve the highest level of sterility assurance and regulatory compliance for our products and for those of our contract manufacturing clients. Partnering with Bosch adds expertise to our project team that ensures a successful manufacturing platform implementation."
Miroslav Horvat, Sales Manager at Bosch Product Division Pharma Liquid said, "Bosch is excited to provide the technology and knowledge which Pharmalucence needs to implement their new drug production asset in Massachusetts. Upon completion, Pharmalucence will offer New England's first advanced barrier isolated aseptic fill and finish facility operating in the contract manufacturing market. We appreciate that Pharmalucence has recognized our high level of expertise in pharmaceutical manufacturing equipment design and construction."
Pharmalucence expects to take delivery of the isolated filling line by late Spring 2012. It is anticipated that the line will be available for commercial product production in early 2013.
Sapio Sciences introduces Sapio GMP LIMS offering unmatched flexibility for unique manufacturing processes